Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
36M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.21M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$4.22M
-
Value change
-
+$3.56M
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$3.49
Significant Holders of RenovoRx, Inc. - Common Stock (RNXT) as of Q1 2023
13 filings reported holding RNXT - RenovoRx, Inc. - Common Stock as of Q1 2023.
RenovoRx, Inc. - Common Stock (RNXT) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.21M shares
of 36M outstanding shares and own 3.37% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (983K shares), COHEN LAWRENCE B (97.2K shares), VANGUARD GROUP INC (45.2K shares), GEODE CAPITAL MANAGEMENT, LLC (42.1K shares), Cambridge Investment Research Advisors, Inc. (14.9K shares), Affinity Capital Advisors, LLC (13.3K shares), LEVEL FOUR ADVISORY SERVICES, LLC (10K shares), Tower Research Capital LLC (TRC) (3.6K shares), UBS Group AG (2.53K shares), and MORGAN STANLEY (176 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.